Insilico Medicine
All companiesCompany report · generated from Insilico Medicine's indicators
Insilico Medicine — full AI read
Insilico Medicine (AI Drug Discovery, HKG) — $1bn market cap. AI Influence (AII) 51.4 (#150/208 most AI-influential), Corporate Power 18.1. Its standout dimension is Frontier capability (62.0, Strong).
Sector
AI Drug Discovery
HQ
Hong Kong, HKG
Ownership
Private
Revenue
$0bn
Market cap / valuation
$1bn
Employees
0k
AI Influence (AII)
51.4
Corporate Power (CPX)
18.1
Dimension read
| Dimension | Value | Standing | What a high vs low value means — and where Insilico Medicine sits |
|---|---|---|---|
| AII AI Influence (AII) | 51.4 | Developing · #150/208 | Low here — limited influence over AI's direction. ▲ high: a company that powerfully shapes the AI world · ▼ low: limited influence over AI's direction |
| CPX Corporate Power (CPX) | 18.1 | Lagging · #325/348 | Low here — limited absolute power to shape global affairs. ▲ high: a civilization-shaping heavyweight — vast market cap, reach and strategic leverage · ▼ low: limited absolute power to shape global affairs |
| Frontier capability Frontier capability | 62.0 | Strong · #77/348 | High here — at or defining the AI frontier (model quality & research). ▲ high: at or defining the AI frontier (model quality & research) · ▼ low: far from the AI frontier |
| AI criticality AI criticality | 48.0 | Moderate · #150/348 | Mid-pack. High would mean a foundational chokepoint the AI ecosystem is built on; low would mean not critical to the AI ecosystem. ▲ high: a foundational chokepoint the AI ecosystem is built on · ▼ low: not critical to the AI ecosystem |
| Leadership influence Leadership influence | 50.0 | Moderate · #203/348 | Mid-pack. High would mean led by a major AI/world power-broker; low would mean leadership with limited outside influence. ▲ high: led by a major AI/world power-broker · ▼ low: leadership with limited outside influence |
| AI momentum AI momentum | 78.0 | Strong · #97/348 | High here — surging adoption and mindshare. ▲ high: surging adoption and mindshare · ▼ low: flat or fading AI momentum |
| CAI Corporate AI (CAI) | 69.8 | Moderate · #112/348 | Mid-pack. High would mean an AI leader — deep adoption, talent and AI-centric products; low would mean an AI laggard relative to peers. ▲ high: an AI leader — deep adoption, talent and AI-centric products · ▼ low: an AI laggard relative to peers |
| AI-stack independence AI-stack independence | 45.0 | Strong · #102/348 | High here — owns its own models, AI silicon and cloud — vertically independent. ▲ high: owns its own models, AI silicon and cloud — vertically independent · ▼ low: depends on others' models, chips or cloud |
| Strategic leverage Strategic leverage | 44.0 | Lagging · #330/348 | Low here — limited leverage beyond its size. ▲ high: outsized sway over policy, markets and standards · ▼ low: limited leverage beyond its size |
Strengths
- Frontier capability (62.0, Strong) — at or defining the AI frontier (model quality & research).
- AI momentum (78.0, Strong) — surging adoption and mindshare.
- AI-stack independence (45.0, Strong) — owns its own models, AI silicon and cloud — vertically independent.
Risk factors
- Immature AI governance (50): responsible-AI controls trail capability — a reputational/regulatory exposure.
- Relative weakness — Strategic leverage (44.0, Lagging): limited leverage beyond its size.
▲
These are model outputs and scenarios, not forecasts of actual outcomes. This platform measures access to, utilization of, and leverage from cognitive infrastructure — not intelligence. No causality or certainty is claimed.